Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;184(6):1187-1190.
doi: 10.1111/bjd.19806. Epub 2021 Mar 1.

COVID-19-associated cutaneous manifestations: does human herpesvirus 6 play an aetiological role?

I Abadías-Granado  1 , A Navarro-Bielsa  1 , A M Morales-Callaghan  1 , L Roc  2 , C C Suso-Estívalez  3 , M Povar-Echeverría  3 , Y Gilaberte  1
Affiliations
Comment

COVID-19-associated cutaneous manifestations: does human herpesvirus 6 play an aetiological role?

I Abadías-Granado et al. Br J Dermatol. 2021 Jun.
No abstract available

PubMed Disclaimer

Comment on

  • Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
    Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain-López D, Llamas Velasco M, García-Gavín J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras Nart I, Selda-Enriquez G, Romaní J, Fustà-Novell X, Melian-Olivera A, Roncero Riesco M, Burgos-Blasco P, Sola Ortigosa J, Feito Rodriguez M, García-Doval I. Galván Casas C, et al. Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10. Br J Dermatol. 2020. PMID: 32348545 Free PMC article.

References

    1. Galván Casas C, Català A, Carretero Hernández G. et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183:71–7. - PMC - PubMed
    1. Criado PR, Abdalla BMZ, Assis IC. et al. Are the cutaneous manifestations during or due to SARS‐CoV‐2 infection/COVID‐19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res 2020; 69:745–56. - PMC - PubMed
    1. Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19. J Med Virol 2021; 10.1002/jmv.26549. - DOI - PMC - PubMed
    1. Dursun R, Temiz SA. The clinics of HHV‐6 infection in COVID‐19 pandemic: Pityriasis rosea and Kawasaki disease. Dermatol Ther 2020; 33:e13730. - PMC - PubMed
    1. Kutlu Ö, Metin A. Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID‐19 pandemic. Dermatol Ther 2020; 33:e14096. - PubMed